Linda J. Johnston, Nicholas J.C. King 

Slides:



Advertisements
Similar presentations
Volume 6, Issue 4, Pages (October 2009)
Advertisements

Shamim A. Mollah, Joseph S. Dobrin, Rachel E
Volume 25, Issue 1, Pages (July 2006)
Mouse Lymphoid Tissue Contains Distinct Subsets of Langerin/CD207+ Dendritic Cells, Only One of Which Represents Epidermal-Derived Langerhans Cells  Patrice.
Critical Role for Skin-Derived Migratory DCs and Langerhans Cells in TFH and GC Responses after Intradermal Immunization  Clément Levin, Olivia Bonduelle,
Cutaneous RANK–RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans.
A Chronic Contact Eczema Impedes Migration of Antigen-Presenting Cells in Alopecia Areata  Pooja Gupta, Pia Freyschmidt-Paul, Mario Vitacolonna, Sabine.
Gregory D. Rak, Lisa C. Osborne, Mark C. Siracusa, Brian S
Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells 
EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen  Takeshi Ouchi, Gaku Nakato,
Corticosteroids But Not Pimecrolimus Affect Viability, Maturation and Immune Function of Murine Epidermal Langerhans Cells  Wolfram Hoetzenecker, Josef.
Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis
Volume 40, Issue 2, Pages (February 2014)
Reduced Inflammatory Threshold Indicates Skin Barrier Defect in Transglutaminase 3 Knockout Mice  Peter Bognar, Ilona Nemeth, Balazs Mayer, Dora Haluszka,
Flow Cytometry Journal of Investigative Dermatology
The Late Endosomal Adaptor Molecule p14 (LAMTOR2) Regulates TGFβ1-Mediated Homeostasis of Langerhans Cells  Florian Sparber, Christoph H. Tripp, Kerstin.
Mouse Lymphoid Tissue Contains Distinct Subsets of Langerin/CD207+ Dendritic Cells, Only One of Which Represents Epidermal-Derived Langerhans Cells  Patrice.
CD69 Modulates Sphingosine-1-Phosphate-Induced Migration of Skin Dendritic Cells  Amalia Lamana, Pilar Martin, Hortensia de la Fuente, Laura Martinez-Muñoz,
Interaction of HSV-1 Infected Peripheral Blood Mononuclear Cells with Cultured Dermal Microvascular Endothelial Cells: a Potential Model for the Pathogenesis.
Immunopathologic Features of Allergic Contact Dermatitis in Humans: Participation of Plasmacytoid Dendritic Cells in the Pathogenesis of the Disease? 
Enrichment for Living Murine Keratinocytes from the Hair Follicle Bulge with the Cell Surface Marker CD34  Rebecca J. Morris, Carl D. Bortner, George.
Akiko Nishibu, Brant R. Ward, James V. Jester, Hidde L
Sandra Holzmann, BSc, Christoph H
Langerhans Cells Are Required for UVR-Induced Immunosuppression
Marie-Thérèse Leccia  Journal of Investigative Dermatology 
Volume 23, Issue 6, Pages (December 2005)
IL-10-Producing Langerhans Cells and Regulatory T Cells Are Responsible for Depressed Contact Hypersensitivity in Grafted Skin  Ryutaro Yoshiki, Kenji.
Diminished Lymphocyte Adhesion and Alleviation of Allergic Responses by Small- Molecule- or Antibody-Mediated Inhibition of L-Selectin Functions  Gertie.
Natural Killer T Cells Are Essential for the Development of Contact Hypersensitivity in BALB/c Mice  Chihiro Shimizuhira, Atsushi Otsuka, Tetsuya Honda,
Identification of TROP2 (TACSTD2), an EpCAM-Like Molecule, as a Specific Marker for TGF-β1-Dependent Human Epidermal Langerhans Cells  Gregor Eisenwort,
Interleukin-1β But Not Tumor Necrosis Factor is Involved in West Nile Virus-Induced Langerhans Cell Migration from the Skin in C57BL/6 Mice  Scott N.
Matthew J. Deeths, Bart T. Endrizzi, Michelle L. Irvin, Lynne P
Martin P. Keough, Candace S. Hayes, Karen DeFeo, Susan K. Gilmour 
Volume 37, Issue 5, Pages (November 2012)
Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity  Andrea Braun, Nadin Dewert, Fiona Brunnert, Viktor.
Differential Effects of Corticosteroids and Pimecrolimus on the Developing Skin Immune System in Humans and Mice  Simone Meindl, Christine Vaculik, Josef.
Clemens Esche, Vladimir M
Karin E. de Visser, Lidiya V. Korets, Lisa M. Coussens  Cancer Cell 
CD24a Expression Levels Discriminate Langerhans Cells from Dermal Dendritic Cells in Murine Skin and Lymph Nodes  Susanne Stutte, Bettina Jux, Charlotte.
Volume 29, Issue 6, Pages (December 2008)
Impaired Initiation of Contact Hypersensitivity by FTY720
Epidermal Langerhans Cell Depletion After Artificial Ultraviolet B Irradiation of Human Skin In Vivo: Apoptosis Versus Migration  Wendy Kölgen, Hilde.
Epidermal Langerhans Cells Rapidly Capture and Present Antigens from C-Type Lectin- Targeting Antibodies Deposited in the Dermis  Vincent Flacher, Christoph.
Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy  Dmitry V. Chebotaev,
Parichat Duangkhae, Geza Erdos, Kate D. Ryman, Simon C
Dermal Dendritic Cells Associated with T Lymphocytes in Normal Human Skin Display an Activated Phenotype  Alexander D. McLellan, Axel Heiser, Rüdiger.
Human Dendritic Cells as Targets of Dengue Virus Infection
The Human Hair Follicle: A Reservoir of CD40+ B7-Deficient Langerhans Cells that Repopulate Epidermis After UVB Exposure  Anita C. Gilliam, Inger B. Kremer,
Murine Epidermal Label-Retaining Cells Isolated by Flow Cytometry do not Express the Stem Cell Markers CD34, Sca-1, or Flk-1  Michael R. Albert, Ruth-Ann.
Overexpression of IL-4 Alters the Homeostasis in the Skin
B Cells Activated in Lymph Nodes in Response to Ultraviolet Irradiation or by Interleukin-10 Inhibit Dendritic Cell Induction of Immunity  Scott N. Byrne,
Timothy J. Paradis, Susan H. Cole, Robin T. Nelson, Ronald P. Gladue 
Volume 6, Issue 4, Pages (October 2009)
Engagement of CD47 Inhibits the Contact Hypersensitivity Response Via the Suppression of Motility and B7 Expression by Langerhans Cells  Xijun Yu, Atsushi.
Yoshiharu Kawaguchi  Journal of Investigative Dermatology 
TGFβ1 Overexpression by Keratinocytes Alters Skin Dendritic Cell Homeostasis and Enhances Contact Hypersensitivity  Javed Mohammed, Andrew J. Gunderson,
Hirotake Suzuki, Binghe Wang, Gulnar M
Sandra Holzmann, BSc, Christoph H
Alterations in Fibroblast α1β1 Integrin Collagen Receptor Expression in Keloids and Hypertrophic Scars  Greg Szulgit  Journal of Investigative Dermatology 
Expression of Mast Cell Growth Modulating and Chemotactic Factors and their Receptors in Human Cutaneous Scars  Barbara Hermes  Journal of Investigative.
Mridula Vishwanath, Akiko Nishibu, Sem Saeland, Brant R
Topical Application of Sphingosine-1-Phosphate and FTY720 Attenuate Allergic Contact Dermatitis Reaction through Inhibition of Dendritic Cell Migration 
Tumor Necrosis Factor-α- and IL-4-Independent Development of Langerhans Cell-Like Dendritic Cells from M-CSF-Conditioned Precursors  Jean-Baptiste Barbaroux,
Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection  Marc Beyer, MD, Holger Bartz, MD, Katharina Hörner,
Marta E. Polak, Louise Newell, Vadim Y
Skin-Infiltrating Monocytes/Macrophages Migrate to Draining Lymph Nodes and Produce IL-10 After Contact Sensitizer Exposure to UV-Irradiated Skin  Eiko.
Volume 36, Issue 5, Pages (May 2012)
Patrizia Stoitzner, Christoph H
Adenosine Slows Migration of Dendritic Cells but Does Not Affect Other Aspects of Dendritic Cell Maturation  Susanne Hofer, Lennart Ivarsson, Patrizia.
Dendritic Cells Require T Cells for Functional Maturation In Vivo
Presentation transcript:

Langerhans Cells Migrate to Local Lymph Nodes Following Cutaneous Infection with an Arbovirus  Linda J. Johnston, Nicholas J.C. King  Journal of Investigative Dermatology  Volume 114, Issue 3, Pages 560-568 (March 2000) DOI: 10.1046/j.1523-1747.2000.00904.x Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 FITC+ cell numbers are increased in lymph nodes draining virus-injected skin. DLN cells were collected 24 h (A) and 48 h (C) after intradermal injection with vehicle, SFV, WNV, or no injection and topical application of 1% FITC 18 h prior to being killed. Total cell numbers per local lymph node are shown for 24 h (B) and 48 h (D) after intradermal injection. Data shown are the mean ± SEM of four experiments, each making use of three or four animals. *p <0.05, **p <0.01 (Student’s t test compared with vehicle-injected animals). Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 (A) FITC+ cells in the lymph nodes draining virus-injected skin are NLDC145+ and MHC class II+. DLN cells collected from mice 18 h after topical application of 1% FITC and 24 h after injection with vehicle, SFV, or WNV were labeled with NLDC145 or MHC class II antibodies. Numbers in the right upper quadrant are the percentage of double-positive cells. Representative data are shown here and these data were similar in three replicate experiments, each making use of the amalgamated cells of three or four animals. (B) Gated high forward/high side scatter, FITC+ cells in the lymph nodes draining virus-injected skin are NLDC145+. DLN cells collected from mice 18 h after topical application of 1% FITC and 24 h after injection with vehicle, SFV, or WNV were labeled with NLDC145. Values in the right upper quadrant (FITC+/NLDC145+) in order from top to bottom are: absolute number of cells in the sample of 50,000 events, absolute percentage of cells and percentage of FITC+/NLDC145+ cells relative to the gated high forward/high side scatter population. Representative data are shown here and these data were similar in three replicate experiments, each making use of the amalgamated cells of three or four animals. Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Increased DC numbers in the DLN of virus-injected skin are independent of the application of FITC. Numbers of NLDC145+ cells per DLN were determined at 24 h (A) and 48 h (C) after intradermal injection with vehicle, SFV, or WNV. Total cell numbers per DLN are also shown at 24 h (B) and 48 h (D) after intradermal injection. Data shown are the mean ± SEM of four experiments, each making use of three or four animals. *p <0.05, **p <0.01 (Student’s t test compared with vehicle-injected animals). Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Langerhans cell morphology is altered in response to virus injection. Epidermal sheets were labeled with NLDC145 48 h after intradermal injection of vehicle (A) or SFV (B). Changes in morphology and density were similar if Langerhans cells were stained for MHC class II, as shown in epidermal sheets prepared from intradermal vehicle-injected (C) or WNV-injected (D) mice after 48 h. Scale bar: 10 μM. Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Langerhans cell density is decreased in the epidermis of virus-injected mice. NLDC145+ cell density in epidermal sheets at 24 h (A) or 48 h (B) after intradermal injection with vehicle, SFV, or WNV was determined by automated image analysis. Data shown are the mean ± SEM of three experiments, each making use of five animals. *p <0.05, **p <0.01 (Student’s t test compared with vehicle-injected animals). Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 The Langerhans cell migratory response requires injection of live virus. DLN cells were collected at 24 h (A) and 48 h (C) after intradermal injection with vehicle, SFV, UV-inactivated SFV (UV-SFV), WNV, or UV-inactivated WNV (UV-WNV) and topical application of 1% FITC 18 h prior to sacrifice. Total cell numbers per local lymph node are shown for 24 h (B) and 48 h (D) after intradermal injection. Data shown are the mean ± SEM of four experiments, each making use of three or four animals. *p <0.05, **p <0.01, NS not significant (Student’s t test compared with vehicle-injected animals). Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 7 E-cadherin expression-positive cell numbers are altered during viral infection. Two-color immunofluorescence analysis of E-cadherin and MHC class II expression on epidermal cells 24 h (left-hand panels) and lymph node cells 48 h (right-hand panels) after injection with vehicle (B), SFV (C), WNV (D), UV-inactivated SFV (E), and UV-inactivated WNV (F). Immunoglobulin control versus MHC class II is shown in (A). Representative data are shown here and these data were similar in three replicate experiments, each making use of the amalgamated cells of three or four animals. Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 8 UV-inactivated WNV and SFV do not cause in vivo phenotypic changes in epidermal cells. Smoothed flow cytometric histograms of MHC-I-labeled epidermal cells are shown in the upper panels after 24 h WNV (A) and SFV (B) infection. Lower panels show zoomed detail in smoothed flow cytometric histograms of MHC class II-labeled epidermal cells, representing MHC class IIhi Langerhans cells, after 24 h WNV (C) and SFV (D). Mock-infected, live virus infected, UV-inactivated virus-infected and isotype control labeled epidermal cell histograms are shown as profiles a, b, c, and d, respectively, in all panels. Representative data are shown here and these data were similar in three replicate experiments, each making use of the amalgamated cells of three or four animals. Journal of Investigative Dermatology 2000 114, 560-568DOI: (10.1046/j.1523-1747.2000.00904.x) Copyright © 2000 The Society for Investigative Dermatology, Inc Terms and Conditions